Mortality and associated factors in patients with systemic sclerosis-associated pulmonary hypertension with and without interstitial lung disease: A long-term follow-up study
Modern Rheumatology · 2025
DOI: 10.1093/mr/roae095 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Rheumatology, 2025. Verfasst von Shirkhan Amikishiyev und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Istanbul Faculty of Medicine, Istanbul University, Fatih, Istanbul, Turkey. Hauptthemen laut MEDLINE: Scleroderma, Systemic, Lung Diseases, Interstitial, Hypertension, Pulmonary. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objectives
We aimed to investigate mortality and prognostic factors in systemic sclerosis (SSc) patients with pulmonary hypertension (PH) with or without interstitial lung disease (ILD).
Methods
The associations between mortality and demographics, transthoracic echocardiography, right heart catheterization (RHC), pulmonary functional parameters at baseline, and treatment modalities were evaluated.
Results
Survival rates for PH-SSc patients (42 female, mean age 56.6 ± 13.5, median follow-up 45 months) were 91% at the first year, 75% at 2 years, and 43.1% at 5 years. The majority of the deceased patients had PH + ILD (P = .007). The PH + ILD group had more diffuse skin involvement, anti-Scl-70, high C-reactive protein, low FVC, and lower DLCO. The deceased patients had higher estimated pulmonary arterial systolic pressure (PASP), low cardiac output, and FVC values. Median survival time was significantly better in patients on combined therapy. Mortality-related factors in the PH + ILD group were decreased initial FVC, high estimated PASP, low cardiac output, deteriorated functional class, and monotherapy.
Conclusion
This is the first reported SSc-PH cohort from Turkey by a multidisciplinary team. PH is a severe complication of SSc with high mortality especially in patients with accompanying severe ILD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Rheumatology, Istanbul Faculty of Medicine, Istanbul University, Fatih, Istanbul, Turkey.
- Department of Chest Diseases, Istanbul Faculty of Medicine, Istanbul University, Fatih, Istanbul, Turkey.
- Department of Radiology, İstanbul Faculty of Medicine, İstanbul University, Fatih, Istanbul, Turkey.
- Department of Cardiology, İstanbul Faculty of Medicine, İstanbul University, Fatih, Istanbul, Turkey.
ORCID-Profile: Shirkhan Amikishiyev
Zitieren
APA
Amikishiyev, S., Yalçınkaya, Y., Mammadova, K., Aliyeva, N., Durak, G., Artim-Esen, B., Gül, A., Bilge, A. K., Okumuş, G., & Inanc, M. (2025). Mortality and associated factors in patients with systemic sclerosis-associated pulmonary hypertension with and without interstitial lung disease: A long-term follow-up study. Modern Rheumatology. https://doi.org/10.1093/mr/roae095
Vancouver
Amikishiyev S, Yalçınkaya Y, Mammadova K, Aliyeva N, Durak G, Artim-Esen B, et al. Mortality and associated factors in patients with systemic sclerosis-associated pulmonary hypertension with and without interstitial lung disease: A long-term follow-up study. Modern Rheumatology. 2025. doi:10.1093/mr/roae095
BibTeX
@article{Amikishiyev2025,
author = {Amikishiyev, Shirkhan and Yalçınkaya, Yasemin and Mammadova, Konul and Aliyeva, Numune and Durak, Gorkem and Artim-Esen, Bahar and Gül, Ahmet and Bilge, Ahmet Kaya and Okumuş, Gulfer and Inanc, Murat},
title = {Mortality and associated factors in patients with systemic sclerosis-associated pulmonary hypertension with and without interstitial lung disease: A long-term follow-up study},
journal = {Modern Rheumatology},
year = {2025},
doi = {10.1093/mr/roae095}
}
EUVIMED